Skip to main content
OpenTrials
Completed

NCT Number: NCT05159791

New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries.

Anomalous Aortic Origin of the Coronary Arteries (AAOCA) is a rare congenital disease that may cause sudden death in young subjects. Frequently the first and only presentation is with an acute event (such as myocardial infarction or sudden cardiac deaths) during physical effort. Not only symptoms are often absent, but also provocative tests fail to induce ischemia or related signs, showing in most patients negative results. For these limitations, the decision to undergo corrective surgery is based on the morphologic characteristics without the support of a functional evaluation. The study focused on developing a personalized ischemic risk assessment with the aid of fluid dynamic simulations. The simulation system integrate clinical data from different diagnostic sources and integrate them with coronary blood flow evaluation at rest and during simulated physical effort.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anomalous Coronary Artery Origin Anomalous Coronary Artery Arising From the Opposite Sinus Anomalous Coronary Artery Course Anomalous Coronary Artery With Aortic Origin and Course Between the Great Arteries Cardiovascular Diseases Death Death, Sudden Death, Sudden, Cardiac Heart Arrest Heart Diseases Myocardial Ischemia Pathologic Processes Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Sudden Cardiac Death Vascular Diseases Ventricular Remodeling

Age range

14 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Irccs Policlinico San Donato

San Donato Milanese, MI, 20097, Italy

About this study

Anomalous Aortic Origin of Coronary Arteries (AAOCA) is a congenital condition where one or more coronary vessels originate from an ectopic site within the aorta, such as the opposite or wrong sinus of Valsalva. Its prevalence in the general population, has been estimated between 0.03% and 0.23% depending on the variant evaluated. The anomalous left or right coronary artery, besides its origin, may take 5 different general courses: interarterial, prepulmonic, subpulmonic, retroaortic or retrocardiac. Each of these forms may be subject to cause myocardial ischemia and subsequent sudden death during physical and sport activity.

In most cases, the disease is silent and does not show any symptoms before the sudden cardiac death event (SCD). Only a few AAOCA subjects report symptoms before SCD that usually occurs unexpectedly after a moderate or intense physical activity. It is extremely hard to study the causing factors in a clinical environment due to the stochastic nature of the myocardial ischemic event and the inability to reproduce the exact effort conditions.

Even when a complete assessment is performed, there is no clinical exam that can reproduce sustained exercise conditions responsible for triggering ischemia and SCD. Even if such an exam would exist and provide adequate results, the risk of SCD exceeds the benefits of having a correct diagnosis.

To overcome all the current diagnostic limitations the ideal diagnostic test has to investigate coronary blood supply, myocardial oxygen demand in relation to the physical activity (intensity and duration) required for triggering an ischemic event, without putting the subjects at risk. To date the only possible way to reproduce such conditions is a subject-specific virtual simulation of aortic root and coronary artery integrated with coronary blood flow simulation able to mimic pressure, flow, and oxygen demand characteristics similar to those of intense exercise, in relation to changes that anomalous coronary undergoes under such conditions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a diagnosis of AAOCA of any age will undergo fluid dynamic simulation
  • Patients with age > 14 with diagnosis of AAOCA will undergo to invasive coronary flow measurements
  • Informed consent

Exclusion criteria

  • A presence of major associated congenital heart anomalies
  • Contraindication to the execution of the diagnostic examination requested such as age < 14 years for invasive coronary flow measurements

Treatment and study plan

Invasive coronary blood flow assessment and simulations and fluid dynamic patient specific simulation

Diagnostic Test

The coronary blood flow and its distribution between the anomalous and normal artery will be measured by invasive coronary catheterization. Coronary artery flow will be calculated based on intravascular ultrasound (IVUS) and pressure difference measurements. After the IVUS assessment, a pressure transducer (FFR/iFR probe) will be inserted in the coronary artery for pressure measurements. The measurements will be done in the anomalous and normal coronary arteries in each patient to determine coronary flow distribution. Patient's specific heart parameters will be retrieve from CT, MRI and other diagnostic tests and integrated in the simulation module.

Primary outcomes

  1. Identification of myocardial ischemia on simulation model

    Time frame: 3 years

    Assess myocardial ischemia in the patient's specific model during simulated effort correlating coronary artery blood supply to myocardial oxygen demand.

Secondary outcomes

  1. Invasive coronary flow distribution assessment

    Time frame: During clinical diagnostic evaluation, average 3 months after

    Evaluation of coronary blood flow (ml/min) in anomalous coronary artery and in normal coronary artery.

  2. Integration of different coronary artery imaging modality

    Time frame: During clinical diagnostic evaluation, average 6 months

    CT 3D reconstruction of aorta and coronary artery with aorta and coronary artery cross-sectional area (mm2); IVUS coronary artery reconstruction cross-sectional area (mm2); coronary blood flow quantification (ml/min)

  3. Computational fluid dynamic simulation

    Time frame: 3 years

    Correlation between at rest estimated coronary blood flow (patient's specific FSI model) and the measured invasive coronary blood flow (FFR and derived measures).

  4. In vitro effort fluid dynamic simulation

    Time frame: 3 years

    FSI model effort will be simulated by increasing heart rate (bpm) and pressure (mmHg) that will determine changes in coronary artery cross-sectional area (mm2). The outcome of the FSI effort simulation will be measured as changes in coronary artery blood flow (ml/min)

Sponsors and collaborators

Lead sponsor

IRCCS Policlinico S. Donato

Other

Collaborators

  • University of Pavia

Registry information

Acronym: NECESSARY

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Dec 16, 2021
Registry last updated
Mar 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.